Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Analysis of the polymorphisms EGFR-r521K and ERBB2-I655V in Mexican patients with gastric cancer and premalignant gastric lesions.

Torres-Jasso JH, Bustos-Carpinteyro AR, Marín ME, Santiago E, Leoner C, Flores-Luna L, Torres J, Sánchez-Lopez JY.

Rev Invest Clin. 2013 Mar-Apr;65(2):150-5.

PMID:
23844533
2.

ERBB2 kinase domain mutation in a gastric cancer metastasis.

Lee JW, Soung YH, Kim SY, Park WS, Nam SW, Kim SH, Lee JY, Yoo NJ, Lee SH.

APMIS. 2005 Oct;113(10):683-7.

PMID:
16309427
3.

Epidermal growth factor receptor expression in gastric tumors and its relationship with the germline polymorphisms - 216 G>T, -191 C>A, (CA) n IVS1, and R521K.

Torres-Jasso JH, Bustos-Carpinteyro AR, Garcia-Gonzalez JR, Peregrina-Sandoval J, Cruz-Ramos JA, Santiago-Luna E, Sanchez-Lopez JY.

Indian J Cancer. 2016 Jul-Sep;53(3):345-348. doi: 10.4103/0019-509X.200648.

4.

An association between EGF and EGFR gene polymorphisms with gastric cancer in a Chinese Han population.

Yang G, Rao L, Tian L, Cai X.

Hepatogastroenterology. 2012 Nov-Dec;59(120):2668-71.

PMID:
22534548
5.

EGFR gene polymorphisms -216G>T and -191C>A are risk markers for gastric cancer in Mexican population.

Torres-Jasso JH, Marín ME, Santiago-Luna E, Leoner JC, Torres J, Magaña-Torres MT, Perea FJ, Ibarra B, Sánchez-López JY.

Genet Mol Res. 2015 Mar 13;14(1):1802-7. doi: 10.4238/2015.March.13.8.

6.

Genetic polymorphisms in the EGFR (R521K) and estrogen receptor (T594T) genes, EGFR and ErbB-2 protein expression, and breast cancer risk in Tunisia.

Kallel I, Rebai M, Khabir A, Farid NR, Rebaï A.

J Biomed Biotechnol. 2009;2009:753683. doi: 10.1155/2009/753683. Epub 2009 Jul 14.

7.

HER1 R497K and HER2 I655V polymorphisms are linked to development of breast cancer.

AbdRaboh NR, Shehata HH, Ahmed MB, Bayoumi FA.

Dis Markers. 2013;34(6):407-17. doi: 10.3233/DMA-130989.

8.

Single nucleotide polymorphisms in the promoter region of the E-cadherin gene in gastric cancer: case-control study in a young Mexican population.

Medina-Franco H, Ramos-De la Medina A, Vizcaino G, Medina-Franco JL.

Ann Surg Oncol. 2007 Aug;14(8):2246-9. Epub 2007 Jun 5.

PMID:
17549573
9.

Somatic mutations of ERBB2 kinase domain in gastric, colorectal, and breast carcinomas.

Lee JW, Soung YH, Seo SH, Kim SY, Park CH, Wang YP, Park K, Nam SW, Park WS, Kim SH, Lee JY, Yoo NJ, Lee SH.

Clin Cancer Res. 2006 Jan 1;12(1):57-61.

10.

Epidermal growth factor receptor and human epidermal growth factor receptor 2 gene polymorphisms in endometrial cancer in a Japanese population.

Kitao K, Yoshida S, Kennedy S, Takemura N, Sugimoto M, Deguchi M, Ohara N, Maruo T.

Reprod Sci. 2007 May;14(4):349-57.

PMID:
17644807
11.

Analysis of c-ErbB1/epidermal growth factor receptor and c-ErbB2/HER-2 expression in bronchial dysplasia: evaluation of potential targets for chemoprevention of lung cancer.

Merrick DT, Kittelson J, Winterhalder R, Kotantoulas G, Ingeberg S, Keith RL, Kennedy TC, Miller YE, Franklin WA, Hirsch FR.

Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2281-8.

12.

A single nucleotide polymorphism in the 5' untranslated region of the EGF gene is associated with occurrence and malignant progression of gastric cancer.

Hamai Y, Matsumura S, Matsusaki K, Kitadai Y, Yoshida K, Yamaguchi Y, Imai K, Nakachi K, Toge T, Yasui W.

Pathobiology. 2005;72(3):133-8.

PMID:
15860930
13.

A comprehensive study of the association between the EGFR and ERBB2 genes and glioma risk.

Andersson U, Schwartzbaum J, Wiklund F, Sjöström S, Liu Y, Tsavachidis S, Ahlbom A, Auvinen A, Collatz-Laier H, Feychting M, Johansen C, Kiuru A, Lönn S, Schoemaker MJ, Swerdlow AJ, Henriksson R, Bondy M, Melin B.

Acta Oncol. 2010 Aug;49(6):767-75. doi: 10.3109/0284186X.2010.480980.

PMID:
20446891
14.

Amplification of the c-met, c-erbB-2 and epidermal growth factor receptor gene in human gastric cancers: correlation to clinical features.

Tsugawa K, Yonemura Y, Hirono Y, Fushida S, Kaji M, Miwa K, Miyazaki I, Yamamoto H.

Oncology. 1998 Sep-Oct;55(5):475-81.

PMID:
9732228
15.

Epidermal growth factor receptor and c-erbB-2 contents in unresectable (UICC R1 or R2) gastric cancer.

García I, del Casar JM, Corte MD, Allende MT, García-Muñiz JL, Vizoso F.

Int J Biol Markers. 2003 Jul-Sep;18(3):200-6.

PMID:
14535591
16.

Association of heparanase gene (HPSE-1) single nucleotide polymorphisms with gastric cancer.

Yue Z, Song Y, Wang Z, Luo Y, Jiang L, Xing L, Xu H, Zhang X.

J Surg Oncol. 2010 Jul 1;102(1):68-72. doi: 10.1002/jso.21584.

PMID:
20578081
17.

The EGFR R521K polymorphism influences the risk to develop colorectal cancer.

Martinelli M, Ugolini G, Scapoli L, Rivetti S, Lauriola M, Mattei G, Rosati G, Montroni I, Manaresi A, Zattoni D, Taffurelli M, Solmi R.

Cancer Biomark. 2010-2011;8(2):61-5. doi: 10.3233/DMA-2011-0826.

PMID:
21896992
18.

IL-1ra anti-inflammatory cytokine polymorphism is associated with risk of gastric cancer and chronic gastritis in a Brazilian population, but the TNF-β pro-inflammatory cytokine is not.

Oliveira JG, Duarte MC, Silva AE.

Mol Biol Rep. 2012 Jul;39(7):7617-25. doi: 10.1007/s11033-012-1596-x. Epub 2012 Feb 12.

PMID:
22327782
19.

[Association of the p53 codon 72 polymorphism to gastric cancer risk in a hight risk population of Costa Rica].

Alpízar-Alpízar W, Sierra R, Cuenca P, Une C, Mena F, Pérez-Pérez GI.

Rev Biol Trop. 2005 Sep-Dec;53(3-4):317-24. Spanish.

PMID:
17354442
20.

Manganese superoxide dismutase polymorphism and risk of gastric lesions, and its effects on chemoprevention in a Chinese population.

Tu HK, Pan KF, Zhang Y, Li WQ, Zhang L, Ma JL, Li JY, You WC.

Cancer Epidemiol Biomarkers Prev. 2010 Apr;19(4):1089-97. doi: 10.1158/1055-9965.EPI-09-1174. Epub 2010 Mar 16.

Supplemental Content

Support Center